Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


Not all NHS waste is wasteful


CIVAS is about more than just vial sharing. Although the savings can be a convincing economic argument for operating a CIVAS, the safety benefits conferred through the specific skills founded in the pharmacy aseptic suite and the better labelling of reconsituted product is the main driver. Enhanced stability (and therefore expiry) often results from the assured aseptic preparation too. One thing is for sure - we don't do nearly enough to support adherence. The easy wins will be in high cost therapies like Oral Oncology and HIV antiviral treatment. Secondary care and pharmacy homecare are working together on such initiatives. However, pennies make pounds, and although the NHS Advanced Services have an important part to play in improving everyday adherence, more and improved services will be crucial as we go into the future. Particularly for the hard to reach patients like the housebound that we never see and have very limited opportunity to engage with. A national domiciliary MUR service would make a huge difference.

Posted date

21 NOV 2014

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.